300396 迪瑞医疗
已收盘 08-16 15:00:00
资讯
新帖
简况
迪瑞医疗：公司的客户群体中包括体检医院，设备在院的应用也得到了广泛的认可
证券之星 · 08-14
迪瑞医疗：公司的客户群体中包括体检医院，设备在院的应用也得到了广泛的认可
迪瑞医疗（300396）8月13日主力资金净卖出669.49万元
证券之星 · 08-13
迪瑞医疗（300396）8月13日主力资金净卖出669.49万元
迪瑞医疗（300396）8月12日主力资金净买入2034.56万元
证券之星 · 08-12
迪瑞医疗（300396）8月12日主力资金净买入2034.56万元
迪瑞医疗：公司参股公司致善生物自主研发的两款猴痘病毒核酸检测试剂盒（荧光PCR法）已获得欧盟CE认证
证券之星 · 08-09
迪瑞医疗：公司参股公司致善生物自主研发的两款猴痘病毒核酸检测试剂盒（荧光PCR法）已获得欧盟CE认证
迪瑞医疗获得实用新型专利授权：“一种低噪音的大容量微量注射泵”
证券之星 · 08-07
迪瑞医疗获得实用新型专利授权：“一种低噪音的大容量微量注射泵”
迪瑞医疗：回购注销186.58万股限制性股票
证券 · 08-05
迪瑞医疗：回购注销186.58万股限制性股票
迪瑞医疗：二级市场股价走势受多重因素影响，做好投资者保护工作需要有关各方共同努力
证券之星 · 08-02
迪瑞医疗：二级市场股价走势受多重因素影响，做好投资者保护工作需要有关各方共同努力
迪瑞医疗：发挥仪器多元化优势 助力医疗新基建
市场资讯 · 08-01
迪瑞医疗：发挥仪器多元化优势 助力医疗新基建
7月31日迪瑞医疗涨6.54%，信澳健康中国混合A基金重仓该股
证券之星 · 07-31
7月31日迪瑞医疗涨6.54%，信澳健康中国混合A基金重仓该股
迪瑞医疗（300396）7月31日主力资金净买入1317.40万元
证券之星 · 07-31
迪瑞医疗（300396）7月31日主力资金净买入1317.40万元
迪瑞医疗（300396）7月26日主力资金净卖出356.61万元
证券之星 · 07-26
迪瑞医疗（300396）7月26日主力资金净卖出356.61万元
迪瑞医疗：公司将不懈努力，巩固核心价值，以实现公司长期高质量发展和行业领先地位
证券之星 · 07-25
迪瑞医疗：公司将不懈努力，巩固核心价值，以实现公司长期高质量发展和行业领先地位
迪瑞医疗：2020年公司控制权转让双方已经交易完毕，不存在抽屉协议
证券之星 · 07-24
迪瑞医疗：2020年公司控制权转让双方已经交易完毕，不存在抽屉协议
7月23日迪瑞医疗跌5.34%，信澳健康中国混合A基金重仓该股
证券之星 · 07-23
7月23日迪瑞医疗跌5.34%，信澳健康中国混合A基金重仓该股
迪瑞医疗（300396）7月23日主力资金净卖出312.48万元
证券之星 · 07-23
迪瑞医疗（300396）7月23日主力资金净卖出312.48万元
迪瑞医疗：迪瑞医疗根据存量情况以及总体产品价格规划正在积极参与各项集采
证券之星 · 07-22
迪瑞医疗：迪瑞医疗根据存量情况以及总体产品价格规划正在积极参与各项集采
迪瑞医疗（300396）7月22日主力资金净买入170.88万元
证券之星 · 07-22
迪瑞医疗（300396）7月22日主力资金净买入170.88万元
迪瑞医疗：免疫产品正在参与集采，公司将全力以赴以确保业务稳定发展
证券之星 · 07-19
迪瑞医疗：免疫产品正在参与集采，公司将全力以赴以确保业务稳定发展
迪瑞医疗：集采的逐步深入是必然趋势，公司在战略制定方面已经有相应的应对策略
证券之星 · 07-18
迪瑞医疗：集采的逐步深入是必然趋势，公司在战略制定方面已经有相应的应对策略
迪瑞医疗（300396）7月17日主力资金净买入610.76万元
证券之星 · 07-17
迪瑞医疗（300396）7月17日主力资金净买入610.76万元
加载更多
公司概况
公司名称：
迪瑞医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2014-09-10
主营业务：
迪瑞医疗科技股份有限公司主营业务为医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。公司产品主要包括尿液分析、生化分析、血细胞分析、化学发光免疫分析、妇科分泌物分析、凝血分析、整体化实验室七大系列。
发行价格：
29.54
{"stockData":{"symbol":"300396","market":"SZ","secType":"STK","nameCN":"迪瑞医疗","latestPrice":17.15,"timestamp":1723791789000,"preClose":16.49,"halted":0,"volume":11651234,"delay":0,"floatShares":272000000,"shares":273000000,"eps":1.1723,"marketStatus":"已收盘","marketStatusCode":5,"change":0.66,"latestTime":"08-16 15:00:00","open":16.44,"high":17.33,"low":16.18,"amount":196000000,"amplitude":0.0697,"askPrice":17.16,"askSize":139,"bidPrice":17.15,"bidSize":460,"shortable":0,"etf":0,"ttmEps":1.1723,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":16.49,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":18.14,"lowLimit":14.84,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":272700161,"pbRate":2.08,"roa":"--","roe":"5.8%","epsLYR":1.01,"committee":-0.026846,"marketValue":4677000000,"floatMarketCap":4672000000,"peRate":14.629361,"changeRate":0.04,"turnoverRate":0.0428,"status":0},"requestUrl":"/m/hq/s/300396","defaultTab":"news","newsList":[{"id":"2459120072","title":"迪瑞医疗：公司的客户群体中包括体检医院，设备在院的应用也得到了广泛的认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2459120072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459120072?lang=zh_cn&edition=full","pubTime":"2024-08-14 20:01","pubTimestamp":1723636862,"startTime":"0","endTime":"0","summary":"如瑞慈等，公司现有的设备除了在三甲级医院以外，很多设备在体检医院也是贴合使用的！公司的客户群体中包括体检医院，设备在院的应用也得到了广泛的认可。谢谢迪瑞医疗董秘：公司始终坚持以市场需求为导向，仪器和试剂相互促进，同时也在积极寻求内生增长和外延扩张的平衡。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081400041765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300396","BK0251","BK0077"],"gpt_icon":0},{"id":"2459942990","title":"迪瑞医疗（300396）8月13日主力资金净卖出669.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459942990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459942990?lang=zh_cn&edition=full","pubTime":"2024-08-13 15:23","pubTimestamp":1723533793,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月13日收盘，迪瑞医疗报收于16.71元，下跌3.13%，换手率3.48%，成交量9.48万手，成交额1.58亿元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：迪瑞医疗2024年一季报显示，公司主营收入6.63亿元，同比上升99.6%；归母净利润1.22亿元，同比上升56.73%；扣非净利润1.19亿元，同比上升55.53%；负债率33.57%，投资收益624.08万元，财务费用124.66万元，毛利率36.4%。迪瑞医疗主营业务：医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081300025170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0028","BK0077","BK0251"],"gpt_icon":0},{"id":"2458627013","title":"迪瑞医疗（300396）8月12日主力资金净买入2034.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458627013","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458627013?lang=zh_cn&edition=full","pubTime":"2024-08-12 15:19","pubTimestamp":1723447154,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年8月12日收盘，迪瑞医疗报收于17.25元，上涨3.73%，换手率5.47%，成交量14.91万手，成交额2.58亿元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：迪瑞医疗2024年一季报显示，公司主营收入6.63亿元，同比上升99.6%；归母净利润1.22亿元，同比上升56.73%；扣非净利润1.19亿元，同比上升55.53%；负债率33.57%，投资收益624.08万元，财务费用124.66万元，毛利率36.4%。迪瑞医疗主营业务：医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081200013164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0251","300396","BK0028"],"gpt_icon":0},{"id":"2458559716","title":"迪瑞医疗：公司参股公司致善生物自主研发的两款猴痘病毒核酸检测试剂盒（荧光PCR法）已获得欧盟CE认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2458559716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458559716?lang=zh_cn&edition=full","pubTime":"2024-08-09 17:02","pubTimestamp":1723194156,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗(300396)08月09日在投资者关系平台上答复投资者关心的问题。投资者：尊敬的董秘您好，请问公司有关于猴痘检测方面的设备或者试剂吗？迪瑞医疗董秘：公司参股公司致善生物自主研发的两款猴痘病毒核酸检测试剂盒（荧光PCR法）已获得欧盟CE认证。公司将根据市场需求，借助国内和国际市场渠道优势，积极发挥与参股公司协同效应。感谢关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080900034909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300396","BK0251","BK0077"],"gpt_icon":0},{"id":"2457077601","title":"迪瑞医疗获得实用新型专利授权：“一种低噪音的大容量微量注射泵”","url":"https://stock-news.laohu8.com/highlight/detail?id=2457077601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457077601?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:31","pubTimestamp":1722969067,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示迪瑞医疗新获得一项实用新型专利授权，专利名为“一种低噪音的大容量微量注射泵”，专利申请号为CN202323262324.6，授权日为2024年8月6日。今年以来迪瑞医疗新获得专利授权12个，较去年同期增加了71.43%。结合公司2023年年报财务数据，2023年公司在研发方面投入了1.29亿元，同比增12.02%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080700003402.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300396","BK0251","BK0077"],"gpt_icon":0},{"id":"2457775517","title":"迪瑞医疗：回购注销186.58万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775517","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775517?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:26","pubTimestamp":1722864360,"startTime":"0","endTime":"0","summary":"证券日报网讯8月5日晚间，迪瑞医疗发布公告称，根据《上市公司股权激励管理办法》及公司相关激励计划规定，因业绩考核未达标，公司对2021年和2022年限制性股票激励计划中不满足解除限售条件的1，865，750股限制性股票进行回购注销。其中，2021年激励计划涉及486，000股，回购价格为10.85元/股，总金额5，273，100元；2022年激励计划涉及1，379，750股，回购价格为6.86元/股，总金额9，465，085元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-08-05/doc-inchrcxw5536514.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-08-05/doc-inchrcxw5536514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","300396","BK0251","BK0077"],"gpt_icon":0},{"id":"2456470980","title":"迪瑞医疗：二级市场股价走势受多重因素影响，做好投资者保护工作需要有关各方共同努力","url":"https://stock-news.laohu8.com/highlight/detail?id=2456470980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456470980?lang=zh_cn&edition=full","pubTime":"2024-08-02 18:01","pubTimestamp":1722592906,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗08月02日在投资者关系平台上答复投资者关心的问题。二级市场股价走势受多重因素影响，做好投资者保护工作需要有关各方共同努力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080200039067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300396","BK0251","BK0077"],"gpt_icon":0},{"id":"2456171096","title":"迪瑞医疗：发挥仪器多元化优势 助力医疗新基建","url":"https://stock-news.laohu8.com/highlight/detail?id=2456171096","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456171096?lang=zh_cn&edition=full","pubTime":"2024-08-01 16:03","pubTimestamp":1722499380,"startTime":"0","endTime":"0","summary":" 近日，国家发展改革委、财政部印发《关于加力支持大规模设备更新和消费品以旧换新的若干措施》的通知，加大设备更新支持力度，优化设备更新项目支持方式。此前，在设备更新行动方案中已明确加强优质高效医疗卫生体系服务建设。同时，有多个省市均发布了医疗设备更新行动方案。 在“健康中国”、医疗新基建、医疗设备换新等相关政策推进过程中，拥有全自主知识产权产品的迪瑞医疗具有先发优势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/roll/2024-08-01/doc-inchcsyc4738667.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2024-08-01/doc-inchcsyc4738667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159891","BK0028","BK0077","300396","BK0251"],"gpt_icon":0},{"id":"2455472906","title":"7月31日迪瑞医疗涨6.54%，信澳健康中国混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455472906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455472906?lang=zh_cn&edition=full","pubTime":"2024-07-31 16:47","pubTimestamp":1722415645,"startTime":"0","endTime":"0","summary":"证券之星消息，7月31日迪瑞医疗涨6.54%，收盘报16.61元，换手率2.78%，成交量7.22万手，成交额1.18亿元。重仓迪瑞医疗的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为信澳健康中国混合A。信澳健康中国混合A目前规模为9.31亿元，最新净值1.805，较上一交易日下跌0.88%，近一年下跌27.31%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100034228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300396","BK0077","BK0028"],"gpt_icon":0},{"id":"2455974190","title":"迪瑞医疗（300396）7月31日主力资金净买入1317.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455974190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455974190?lang=zh_cn&edition=full","pubTime":"2024-07-31 15:23","pubTimestamp":1722410628,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月31日收盘，迪瑞医疗报收于16.61元，上涨6.54%，换手率2.78%，成交量7.22万手，成交额1.18亿元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：迪瑞医疗2024年一季报显示，公司主营收入6.63亿元，同比上升99.6%；归母净利润1.22亿元，同比上升56.73%；扣非净利润1.19亿元，同比上升55.53%；负债率33.57%，投资收益624.08万元，财务费用124.66万元，毛利率36.4%。迪瑞医疗主营业务：医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100027155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0251","BK0077","BK0028"],"gpt_icon":0},{"id":"2454633396","title":"迪瑞医疗（300396）7月26日主力资金净卖出356.61万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454633396","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454633396?lang=zh_cn&edition=full","pubTime":"2024-07-26 15:23","pubTimestamp":1721978628,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月26日收盘，迪瑞医疗报收于15.66元，下跌0.76%，换手率1.78%，成交量4.61万手，成交额7226.79万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：迪瑞医疗2024年一季报显示，公司主营收入6.63亿元，同比上升99.6%；归母净利润1.22亿元，同比上升56.73%；扣非净利润1.19亿元，同比上升55.53%；负债率33.57%，投资收益624.08万元，财务费用124.66万元，毛利率36.4%。迪瑞医疗主营业务：医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600025500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0251","300396"],"gpt_icon":0},{"id":"2454840345","title":"迪瑞医疗：公司将不懈努力，巩固核心价值，以实现公司长期高质量发展和行业领先地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2454840345","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454840345?lang=zh_cn&edition=full","pubTime":"2024-07-25 18:02","pubTimestamp":1721901748,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗07月25日在投资者关系平台上答复投资者关心的问题。迪瑞医疗董秘：您好，2020年公司控制权转让时双方已经交易完毕，近期二级市场股价表现不佳，向您表示歉意。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500037663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0077","300396","BK0028"],"gpt_icon":0},{"id":"2453070451","title":"迪瑞医疗：2020年公司控制权转让双方已经交易完毕，不存在抽屉协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2453070451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453070451?lang=zh_cn&edition=full","pubTime":"2024-07-24 19:02","pubTimestamp":1721818922,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗07月24日在投资者关系平台上答复投资者关心的问题。迪瑞医疗董秘：2020年公司控制权转让双方已经交易完毕，不存在抽屉协议。迪瑞医疗董秘：公司国内重点市场以东北市场、京津冀市场、长三角及川渝地区等为主，同时产品远销海外120多个国家及地区。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072400041626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0251","BK0028","BK0077"],"gpt_icon":0},{"id":"2453700855","title":"7月23日迪瑞医疗跌5.34%，信澳健康中国混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2453700855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453700855?lang=zh_cn&edition=full","pubTime":"2024-07-23 16:21","pubTimestamp":1721722863,"startTime":"0","endTime":"0","summary":"证券之星消息，7月23日迪瑞医疗跌5.34%创60日新低，收盘报15.96元，换手率3.07%，成交量7.97万手，成交额1.29亿元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为信澳健康中国混合A。信澳健康中国混合A目前规模为9.31亿元，最新净值1.912，较上一交易日上涨0.68%，近一年下跌21.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300029735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300396","BK0251","BK0077"],"gpt_icon":0},{"id":"2453709472","title":"迪瑞医疗（300396）7月23日主力资金净卖出312.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453709472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453709472?lang=zh_cn&edition=full","pubTime":"2024-07-23 15:28","pubTimestamp":1721719735,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月23日收盘，迪瑞医疗报收于15.96元，下跌5.34%，换手率3.07%，成交量7.97万手，成交额1.29亿元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：迪瑞医疗2024年一季报显示，公司主营收入6.63亿元，同比上升99.6%；归母净利润1.22亿元，同比上升56.73%；扣非净利润1.19亿元，同比上升55.53%；负债率33.57%，投资收益624.08万元，财务费用124.66万元，毛利率36.4%。迪瑞医疗主营业务：医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300023680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300396","BK0077","BK0251"],"gpt_icon":0},{"id":"2453875799","title":"迪瑞医疗：迪瑞医疗根据存量情况以及总体产品价格规划正在积极参与各项集采","url":"https://stock-news.laohu8.com/highlight/detail?id=2453875799","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453875799?lang=zh_cn&edition=full","pubTime":"2024-07-22 18:04","pubTimestamp":1721642661,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗07月22日在投资者关系平台上答复投资者关心的问题。甚至可能超越迪瑞。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200024910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300396","BK0251","BK0077"],"gpt_icon":0},{"id":"2453903737","title":"迪瑞医疗（300396）7月22日主力资金净买入170.88万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453903737","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453903737?lang=zh_cn&edition=full","pubTime":"2024-07-22 15:24","pubTimestamp":1721633047,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月22日收盘，迪瑞医疗报收于16.86元，下跌1.81%，换手率2.03%，成交量5.27万手，成交额8939.31万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：迪瑞医疗2024年一季报显示，公司主营收入6.63亿元，同比上升99.6%；归母净利润1.22亿元，同比上升56.73%；扣非净利润1.19亿元，同比上升55.53%；负债率33.57%，投资收益624.08万元，财务费用124.66万元，毛利率36.4%。迪瑞医疗主营业务：医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200013687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300396","BK0251","BK0077","BK0028"],"gpt_icon":0},{"id":"2452423127","title":"迪瑞医疗：免疫产品正在参与集采，公司将全力以赴以确保业务稳定发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2452423127","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452423127?lang=zh_cn&edition=full","pubTime":"2024-07-19 18:03","pubTimestamp":1721383381,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗07月19日在投资者关系平台上答复投资者关心的问题。今年免疫类产品营收较去年能翻倍吗迪瑞医疗董秘：您好，免疫产品正在参与集采，公司将全力以赴以确保业务稳定发展。下半年尿分和生化产品业务将极速萎缩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071900040351.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0251","300396","BK0077"],"gpt_icon":0},{"id":"2452105188","title":"迪瑞医疗：集采的逐步深入是必然趋势，公司在战略制定方面已经有相应的应对策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2452105188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452105188?lang=zh_cn&edition=full","pubTime":"2024-07-18 18:02","pubTimestamp":1721296949,"startTime":"0","endTime":"0","summary":"证券之星消息，迪瑞医疗07月18日在投资者关系平台上答复投资者关心的问题。期待着您持续关注迪瑞医疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071800037550.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0077","300396","BK0028"],"gpt_icon":0},{"id":"2452864721","title":"迪瑞医疗（300396）7月17日主力资金净买入610.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452864721","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452864721?lang=zh_cn&edition=full","pubTime":"2024-07-17 15:22","pubTimestamp":1721200975,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月17日收盘，迪瑞医疗报收于17.37元，上涨1.76%，换手率1.65%，成交量4.29万手，成交额7414.16万元。近5日资金流向一览见下表：该股主要指标及行业内排名如下：迪瑞医疗2024年一季报显示，公司主营收入6.63亿元，同比上升99.6%；归母净利润1.22亿元，同比上升56.73%；扣非净利润1.19亿元，同比上升55.53%；负债率33.57%，投资收益624.08万元，财务费用124.66万元，毛利率36.4%。迪瑞医疗主营业务：医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700026560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300396","BK0251","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2014-09-10","address":"吉林省长春市朝阳区高新技术产业开发区云河街95号","stockEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":-0.0127},{"period":"3month","weight":-0.308},{"period":"6month","weight":-0.3755},{"period":"1year","weight":-0.2437},{"period":"ytd","weight":-0.406}],"companyName":"迪瑞医疗科技股份有限公司","boardCode":"AI0035","perCapita":"25943股","boardName":"专用设备制造业","registeredCapital":"27270万元","compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0282},{"period":"3month","weight":-0.0871},{"period":"6month","weight":0.0047},{"period":"1year","weight":-0.0899},{"period":"ytd","weight":-0.0321}],"survey":" 迪瑞医疗科技股份有限公司主营业务为医疗检验仪器及配套试纸试剂的研发、生产、营销与服务。公司产品主要包括尿液分析、生化分析、血细胞分析、化学发光免疫分析、妇科分泌物分析、凝血分析、整体化实验室七大系列。","serverTime":1723933392439,"listedPrice":29.54,"stockholders":"10501人(较上一季度增加41.28%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迪瑞医疗(300396)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迪瑞医疗(300396)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迪瑞医疗,300396,迪瑞医疗股票,迪瑞医疗股票老虎,迪瑞医疗股票老虎国际,迪瑞医疗行情,迪瑞医疗股票行情,迪瑞医疗股价,迪瑞医疗股市,迪瑞医疗股票价格,迪瑞医疗股票交易,迪瑞医疗股票购买,迪瑞医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迪瑞医疗(300396)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迪瑞医疗(300396)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}